Answers are grounded in this paper and cite their sources.
Nisin, a penta-cyclic peptide produced by Lactococcus lactis, is the only bacteriocin approved as a food preservation without dosage limitation. The industrial production of nisin is hindered by low fermentation titer because strain cells encounter the obstacles of environmental stress and product inhibition during fermentation process. In this work, a surfactant-assisted symbiotic system of Chlorella pyrenoidosa FACHB-10 and L. lactis ATCC 11454 was developed to promote nisin production. First, the co-culture conditions for two microorganisms were determined. Under the suitable conditions of C. pyrenoidosa FACHB-10 inoculation ratio of 10.0%(v/v), initial pH of 7.3 and nutrient medium of L. lactis ATCC 11454 with addition of 0.1% (v/v) M solution (CaCl2, citric acid and ferric ammonium citrate) and 0.1% (v/v) A5 solution (H3BO3, MnCl2, ZnSO4, Na2MoO4, CuSO4, and Co(NO3)2), the maximum nisin titer reached 3444.29 ± 94.41 IU/mL. To prevent the adsorption of nisin on strain cells, eight surfactants were systematically screened. Tween 60 was selected as the suitable surfactant to support nisin production. Based on response surface design method, the maximum nisin titer reached 5627.43 ± 44.17 IU/mL when Tween 60 concentration and supplementing time were 0.97 g/L and 8.5 h, respectively. This work is expected to offer a sustainable framework for nisin production.
No takes yet. Share an insight, caveat, or question.
Song et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: